Tirzepatide
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly · Phase 3 · Completed · Enrollment 441
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.